Menu
Search
|

Menu

Close
X

NuVasive Inc NUVA.OQ (NASDAQ Stock Exchange Global Select Market)

47.54 USD
-0.67 (-1.39%)
As of 1:17 AM IST
chart
Previous Close 48.21
Open 48.13
Volume 111,013
3m Avg Volume 330,871
Today’s High 48.26
Today’s Low 47.24
52 Week High 81.48
52 Week Low 44.62
Shares Outstanding (mil) 50.80
Market Capitalization (mil) 2,893.28
Forward P/E 91.50
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.11 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY17
758
FY16
962
FY15
811
EPS (USD)
FY17
1.075
FY16
0.685
FY15
1.269
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
91.50
32.90
Price to Sales (TTM)
vs sector
2.83
5.77
Price to Book (MRQ)
vs sector
4.21
5.41
Price to Cash Flow (TTM)
vs sector
19.41
23.42
Total Debt to Equity (MRQ)
vs sector
91.37
16.52
LT Debt to Equity (MRQ)
vs sector
79.78
12.22
Return on Investment (TTM)
vs sector
2.56
14.43
Return on Equity (TTM)
vs sector
5.03
16.13

EXECUTIVE LEADERSHIP

Gregory Lucier
Chairman of the Board, Chief Executive Officer, Since 2015
Salary: $800,000.00
Bonus: --
Rajesh Asarpota
Chief Financial Officer, Executive Vice President, Since 2017
Salary: --
Bonus: --
Joan Stafslien
Executive Vice President, General Counsel, Corporate Secretary, Since 2016
Salary: --
Bonus: --
Carol Cox
Executive Vice President - External Affairs and Corporate Marketing, Since 2015
Salary: --
Bonus: --
Peter Leddy
Executive Vice President, Global Human Resources, Integrations, Real Estate and Internal Communications, Since 2015
Salary: $203,076.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

7475 Lusk Blvd
SAN DIEGO   CA   92121-5707

Phone: +1858.9091800

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

SPONSORED STORIES